Dynavax (DVAX) Reports Q3 Loss of $0.24/sh

Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.24), versus ($0.15) reported last year. Revenue for the quarter came in at $108.3 million, versus $13.41 million reported last year.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• UBS Upgrades Apollo Tyres (APTY:IN) to Buy